Max Almond

3.5k total citations
69 papers, 1.3k citations indexed

About

Max Almond is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Max Almond has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 31 papers in Surgery and 19 papers in Oncology. Recurrent topics in Max Almond's work include Sarcoma Diagnosis and Treatment (20 papers), Spectroscopy Techniques in Biomedical and Chemical Research (12 papers) and Esophageal Cancer Research and Treatment (12 papers). Max Almond is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Spectroscopy Techniques in Biomedical and Chemical Research (12 papers) and Esophageal Cancer Research and Treatment (12 papers). Max Almond collaborates with scholars based in United Kingdom, Italy and United States. Max Almond's co-authors include Hugh Barr, Samuel Ford, Nicholas Stone, Catherine Kendall, Anant Desai, David Gourevitch, Shameen Jaunoo, Neil A. Shepherd, Joanne Hutchings and Gavin R. Lloyd and has published in prestigious journals such as Gut, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Max Almond

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Almond United Kingdom 18 415 398 341 298 278 69 1.3k
Mary Dunne Ireland 17 285 0.7× 130 0.3× 143 0.4× 92 0.3× 117 0.4× 64 902
Shane Killeen Ireland 16 218 0.5× 53 0.1× 271 0.8× 28 0.1× 244 0.9× 40 868
Douglas C. B. Redd United States 16 186 0.4× 503 1.3× 334 1.0× 386 1.3× 28 0.1× 24 1.1k
Lisa R. Dixon United States 14 131 0.3× 71 0.2× 221 0.6× 43 0.1× 132 0.5× 33 625
Barbara J. McKenna United States 24 504 1.2× 66 0.2× 950 2.8× 8 0.0× 404 1.5× 72 2.2k
David Gelmont United States 17 539 1.3× 30 0.1× 190 0.6× 7 0.0× 80 0.3× 38 1.3k
Maurice Anidjar Canada 19 804 1.9× 34 0.1× 443 1.3× 9 0.0× 75 0.3× 99 1.3k
Mojgan Mokhtari Iran 14 77 0.2× 40 0.1× 95 0.3× 11 0.0× 216 0.8× 70 986
Alexandré Pelzer Austria 26 1.1k 2.6× 32 0.1× 316 0.9× 8 0.0× 278 1.0× 98 1.9k
Kaid Darwiche Germany 24 1.4k 3.4× 24 0.1× 299 0.9× 21 0.1× 370 1.3× 138 1.9k

Countries citing papers authored by Max Almond

Since Specialization
Citations

This map shows the geographic impact of Max Almond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Almond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Almond more than expected).

Fields of papers citing papers by Max Almond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Almond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Almond. The network helps show where Max Almond may publish in the future.

Co-authorship network of co-authors of Max Almond

This figure shows the co-authorship network connecting the top 25 collaborators of Max Almond. A scholar is included among the top collaborators of Max Almond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Almond. Max Almond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Judson, Ian, Robin L. Jones, Newton A C S Wong, et al.. (2024). Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines. British Journal of Cancer. 132(1). 1–10. 8 indexed citations
2.
Whitaker, John, Carolyn Nessim, Max Almond, & Samuel Ford. (2023). Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma. Current Oncology. 30(3). 2781–2791. 1 indexed citations
3.
Hodson, James, et al.. (2021). Prognostic implications of histological organ involvement in retroperitoneal sarcoma. BJS Open. 5(5). 7 indexed citations
4.
Wong, Boaz, Sameer Apte, Fabio Tirotta, et al.. (2021). Perioperative blood transfusion is not an independent predictor for worse outcomes in retroperitoneal sarcoma surgery. European Journal of Surgical Oncology. 47(7). 1763–1770. 6 indexed citations
5.
Tirotta, Fabio, Alessandro Parente, Max Almond, et al.. (2021). Comparison of comprehensive complication index and Clavien–Dindo classification in patients with retroperitoneal sarcoma. Journal of Surgical Oncology. 124(7). 1166–1172. 12 indexed citations
6.
Tirotta, Fabio, James Hodson, Alessandro Parente, et al.. (2020). Liver resection for sarcoma metastases: A systematic review and experience from two European centres. European Journal of Surgical Oncology. 46(10). 1807–1813. 10 indexed citations
7.
Tirotta, Fabio, Carlo Morosi, James Hodson, et al.. (2020). Improved Biopsy Accuracy in Retroperitoneal Dedifferentiated Liposarcoma. Annals of Surgical Oncology. 27(11). 4574–4581. 9 indexed citations
8.
Davies, Emma Jane, James Hodson, Phillipe Taniere, et al.. (2020). Tumor necrosis is significantly associated with reduced recurrence‐free survival after curative resection of gastrointestinal stromal tumors. Journal of Surgical Oncology. 123(2). 432–438. 7 indexed citations
9.
Wanigasooriya, Kasun, Philippe Tanière, Max Almond, et al.. (2020). A review of retroperitoneal liposarcoma genomics. Cancer Treatment Reviews. 86. 102013–102013. 42 indexed citations
10.
Almond, Max, Fabio Tirotta, Hannah L. Tattersall, et al.. (2019). Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma. British journal of surgery. 106(4). 395–403. 31 indexed citations
11.
Almond, Max, Alessandro Gronchi, D. Strauß, et al.. (2018). Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. European Journal of Surgical Oncology. 44(5). 571–579. 43 indexed citations
12.
Almond, Max, James Hodson, Samuel Ford, et al.. (2017). Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis. European Journal of Surgical Oncology. 43(10). 1808–1815. 42 indexed citations
13.
Almond, Max, Adrian Warfield, Anant Desai, David Gourevitch, & Samuel Ford. (2017). Biphasic malignant tumours of the abdominal cavity. International Journal of Clinical Oncology. 22(4). 635–640. 5 indexed citations
14.
Ford, Samuel, Max Almond, & Alessandro Gronchi. (2017). An Update on Non-extremity Soft Tissue Sarcomas. Clinical Oncology. 29(8). 516–527. 5 indexed citations
15.
Almond, Max, Keith Roberts, James Hodson, et al.. (2014). Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB. 17(5). 416–421. 34 indexed citations
16.
17.
Lloyd, Gavin R., Max Almond, Nicholas Stone, et al.. (2013). Utilising non-consensus pathology measurements to improve the diagnosis of oesophageal cancer using a Raman spectroscopic probe. The Analyst. 139(2). 381–388. 16 indexed citations
18.
Williamson, James M., et al.. (2012). Current management of Barrett's oesophagus. British Journal of Hospital Medicine. 73(5). 271–277. 3 indexed citations
19.
Almond, Max, Joanne Hutchings, Catherine Kendall, et al.. (2011). Towards real-time ‘biochemical endoscopy’ for diagnosis of early barrett's neoplasia. Gut. 60(Suppl 1). A167.2–A168. 2 indexed citations
20.
Jaunoo, Shameen, et al.. (2009). Postcholecystectomy syndrome (PCS). International Journal of Surgery. 8(1). 15–17. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Dunne Breakdown of academic impact, for papers by Shane Killeen Breakdown of academic impact, for papers by Douglas C. B. Redd Breakdown of academic impact, for papers by Lisa R. Dixon Breakdown of academic impact, for papers by Barbara J. McKenna Breakdown of academic impact, for papers by David Gelmont Breakdown of academic impact, for papers by Maurice Anidjar Breakdown of academic impact, for papers by Mojgan Mokhtari Breakdown of academic impact, for papers by Alexandré Pelzer Breakdown of academic impact, for papers by Kaid Darwiche
Rankless by CCL
2026